India drug regulator approves AstraZeneca COVID vaccine
India's drug regulator is set to approve on Friday a coronavirus vaccine developed by Oxford University and AstraZeneca, for emergency use, according to news agency Reuters reported. The expert committee set up by Drugs Controller General of India (DCGI) V.G. Somani to vet vaccine proposals, met for the second time this week, recommended emergency approval for Oxford-AstraZeneca COVID-19 vaccine. British-Swedish drugmaker inked an agreement with Serum Institute of India to produce 1 billion doses of its experimental vaccine for lower-and-middle income countries.
Countries with relatively basic health infrastructure have high hopes for a shot that, unlike Pfizer’s, can be stored and transported under normal refrigeration, rather than supercooled to -70 degrees Celsius (-94 Fahrenheit).
Source : Reuters
No comments:
Post a Comment